Rainbow Rare Earths Phalaborwa project shaping up to be one of the lowest cost producers globally. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCppgroup Regulatory News (CPP)

Share Price Information for Cppgroup (CPP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 165.50
Bid: 162.00
Ask: 169.00
Change: -1.00 (-0.60%)
Spread: 7.00 (4.321%)
Open: 166.50
High: 0.00
Low: 0.00
Prev. Close: 166.50
CPP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Overallotment option exercise notice

16 Apr 2010 16:52

RNS Number : 3504K
CPPGroup Plc
16 April 2010
 

 

 

 

TO BE RELEASED OUTSIDE THE UNITED STATES ONLY. NOT FOR DISTRIBUTION DIRECTLY OR INDIRECTLY IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, SWITZERLAND, SOUTH AFRICA OR JAPAN

 

FOR IMMEDIATE RELEASE 16 APRIL 2010

Overallotment option exercise notice: CPPGroup Plc

 

In connection with the Global Offer in relation to the following Ordinary Shares:

CPPGroup Plc Ordinary Shares of 10p each

ISIN Code: GB00B5W55H93

 

CPPGroup Plc ("CPP") announces that, in connection with the Global Offer of 63,829,786 Ordinary Shares by CPP, UBS Limited, as stabilising manager, has today given notice to exercise the Over-allotment Option in respect of 6,382,978 Ordinary Shares

 

Including the exercise of the Over-allotment Option, the total number of Ordinary Shares in the Global Offer is 70,212,764. Following the exercise of the Over-allotment Option, Hamish Ogston will own approximately 57.5 per cent. of CPP's Ordinary Shares.

 

The issue price of CPPGroup Plc Ordinary Shares of 10p each was set at 235p on 18 March 2010.

 

The stabilisation period commenced at 8am on 19 March 2010 and ended at the close of business on 16 April 2010

 

 

IMPORTANT NOTICE

 

This announcement is not for publication or distribution, directly or indirectly, in or into the United States. The distribution of this announcement may be restricted by law in certain jurisdictions and persons into whose possession any document or other information referred to herein comes should inform themselves about and observe any such restriction. Any failure to comply with these restrictions may constitute a violation of the securities laws of any such jurisdiction.

 

J.P. Morgan Securities Ltd. and UBS Limited (together, the "Banks") are acting as joint sponsors, joint lead managers, joint global co-ordinators and joint bookrunners in connection with Admission and the Global Offer and as underwriters in connection with the Global Offer.

 

The Banks are acting exclusively for the Company and no-one else in connection with the Global Offer. They will not regard any other person as their client in relation to the Global Offer and will not be responsible to anyone other than the Company for providing the protections afforded to customers of the Banks or for giving advice in relation to the Global Offer, the contents of this announcement or any transaction, arrangement or other matter referred to herein.

 

This announcement does not contain or constitute an offer, or the solicitation of an offer to buy or subscribe for Ordinary Shares, and is not for distribution in, the United States, Canada, Australia, Switzerland, South Africa or Japan, or in any jurisdiction in which distribution is unlawful. The Ordinary Shares have not been and will not be registered under the US Securities Act of 1933, as amended (the "Securities Act") or under the securities laws of South Africa, Canada, Switzerland, Australia or Japan, and may not be offered, sold, transferred or delivered, directly or indirectly, in or into the United States except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act and in compliance with any applicable securities laws of any states or other jurisdiction of the United States.

 

This announcement is for information purposes only and does not constitute an invitation or offer to underwrite, subscribe for or otherwise acquire or dispose of any securities of CPP in any jurisdiction.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCGGUQPCUPUGAQ
Date   Source Headline
18th Mar 20217:00 amRNSChange of Adviser
17th Mar 20217:00 amRNSDirectorate Change
5th Mar 20217:00 amRNSDirectorate Change - Amendment
11th Feb 20217:00 amRNSBlock listing Interim Review
5th Feb 20218:34 amRNSDirectorate Change
18th Jan 20217:00 amRNSTrading Update
21st Dec 20205:32 pmRNSDirector/PDMR Shareholding
17th Dec 202012:26 pmRNSBlock listing Interim Review
30th Nov 20203:47 pmRNSDirectorate Change
13th Nov 20207:00 amRNSDirectorate Change
2nd Nov 202011:38 amRNSTotal Voting Rights
26th Oct 20201:30 pmRNSBlock listing Interim Review
5th Oct 202011:09 amRNSTotal Voting Rights
24th Sep 20207:00 amRNSHalf-year Report
9th Sep 202012:02 pmRNSNon Regulatory - Blink - Lloyds Lab
18th Aug 202010:19 amRNSBusiness Update
13th Aug 20207:17 amRNSBlock listing Interim Review
1st Jul 20208:29 amRNSTotal Voting Rights
30th Jun 20208:08 amRNSBlock listing Interim Review
22nd Jun 20204:08 pmRNSDirector/PDMR Shareholding
9th Jun 20209:37 amRNSDirectorate Change
28th May 202012:32 pmRNSResult of AGM
22nd May 202012:28 pmRNSTotal Voting Rights
20th May 202012:08 pmRNSSecond Price Monitoring Extn
20th May 202012:02 pmRNSPrice Monitoring Extension
19th May 202011:10 amRNSBusiness Update
1st May 20207:00 amRNSDirector/PDMR Shareholding
28th Apr 20203:42 pmRNSNotice of AGM
21st Apr 20202:48 pmRNSDirector/PDMR Shareholding
16th Apr 20207:00 amRNSFinal Results
14th Apr 20203:36 pmRNSAdditional Listing
23rd Mar 20201:17 pmRNSTrading Statement
23rd Mar 20207:00 amRNSStatement re delayed preliminary results
12th Mar 202010:13 amRNSAdditional Listing
24th Feb 202011:40 amRNSBusiness Update
11th Feb 20204:24 pmRNSBlock listing Interim Review
10th Feb 202012:43 pmRNSCPP Group India Risk award
6th Feb 20204:41 pmRNSSecond Price Monitoring Extn
6th Feb 20204:35 pmRNSPrice Monitoring Extension
3rd Feb 20201:22 pmRNSCPP advances technology offering in Turkey
20th Dec 20199:50 amRNSDirector/PDMR Shareholding
16th Dec 201912:08 pmRNSBlock listing Interim Review
12th Dec 201911:16 amRNSDirector/PDMR Shareholding
28th Nov 201911:03 amRNSBusiness Update
12th Nov 20192:40 pmRNSBusiness Update
4th Nov 20194:11 pmRNSTotal Voting Rights
21st Oct 20192:16 pmRNSBusiness update
18th Oct 201912:07 pmRNSSecond Price Monitoring Extn
18th Oct 201912:02 pmRNSPrice Monitoring Extension
1st Oct 20199:04 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.